Using omega-3 fatty acids and nutrition to support cancer patients with muscle loss

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effects of omega-3 enriched nutritional supplements on patients with gastrointestinal cancer who are experiencing sarcopenia, a condition characterized by muscle loss and weakness. The approach involves providing oral nutritional supplements that may enhance immune function and improve overall nutritional status. Patients undergoing systemic treatments such as chemotherapy or immunotherapy will be monitored for changes in muscle mass and strength. The goal is to determine if nutritional support can improve treatment tolerance and quality of life for these patients.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* \- Patients with Gastrointestinal tumor undergoing systemic treatment (chemo-radio-immuno therapy or their combination)
* Body weight loss \>5% in the previous three months or \>10% in the previous six months
* Both sexes
* Age between 18-85 y-old.

Exclusion Criteria:

* Life expectancy \< 2 weeks
* MDRD \< 15 mL/min
* End-stage liver disease
* Any musculoskeletal, cardiovascular and/or neurological disorders that could affect exercising.

Where it's running

• Imibic
  Córdoba, Cordoba, Spain Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Sarcopenia in Patients After Cardiac Surgery

  This observational study tests how common sarcopenia is after cardiac surgery and whether current care helps improve muscle mass and function.

  Recruiting Universitaire Ziekenhuizen KU Leuven · Leuven · NCT07908472

• Bone marrow mesenchymal stem cell injection for sarcopenia

  This study tests whether CG-BM1, a stem cell injection, can be safely given to adults with sarcopenia to see if it helps improve muscle health.

  Recruiting Phase 1/2 GuangZhou Cellgenes Biotechnology Co., Ltd. · Guangzhou · NCT07865676

• GLP-1 receptor agonist use and muscle health in adults with obesity without diabetes

  This study tests whether GLP-1 receptor agonists affect muscle mass and strength in adults with obesity who don’t have diabetes.

  Recruiting Istanbul Saglik Bilimleri University · Istanbul, Kucukcekmece · NCT07858864

• Sarcopenia and Epidural Steroid Injections in Lumbar Spinal Stenosis

  We’re testing how sarcopenia relates to pain, function, and quality of life after a routine interlaminar epidural steroid injection in people with lumbar spinal stenosis.

  Recruiting Marmara University · Istanbul, Istanbul · NCT07855419

• Using Multimodal Ultrasound to Check Muscle Mass in Metabolic Disease Patients

  This study tests whether a multimodal ultrasound approach can accurately measure muscle mass in people with metabolic syndrome, obesity, sarcopenia, or type 2 diabetes.

  Recruiting Zhangzhou Municipal Hospital · Zhangzhou, Fujian · NCT07836088

• Lower-limb rehabilitation robot training with nutrition education for sarcopenia

  In adults aged 60 and older with sarcopenia, this study tests whether adding robot-assisted leg training to nutrition education can improve muscle mass and walking ability compared with usual care.

  Recruiting Taipei Medical University Hospital · Taipei, Taipei City · NCT07830472

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.